Hepavax-Gene

WIPO WIPO 2004

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Hepavax-Gene was filed as Word mark on 01/29/2004 at the World Intellectual Property Organization.

Trademark Details Last update: June 26, 2018

Trademark form Word mark
File reference 818439
Register number 514268
Countries Turkey Bulgaria China Egypt Iran Kazakhstan Romania Russia Ukraine Vietnam
Base trademark CH No. 514268, September 4, 2003
Application date January 29, 2004
Expiration date January 29, 2024

Trademark owner

Rehhagstrasse 79
3018 Bern
CH

Trademark representatives

Hoogoorddreef 5 1101 BA Amsterdam NL

goods and services

05 Pharmaceutical products and vaccines for the treatment or prevention of illnesses including cancer in humans, namely cholera, hepatitis, influenza, cold, yellow fever, mumps, measles, rubella, cystic fibrosis, typhoid fever, human papilloma virus, tetanus, diphtheria, malaria, melanoma, Alzheimer's disease, whooping cough and bacterial and viral infections

Trademark history

Date Document number Area Entry
March 24, 2014 2014/15 Gaz VN Rejection
January 29, 2014 2014/17 Gaz Extension
January 17, 2013 2013/11 Gaz Correction
June 30, 2011 2011/27 Gaz KZ Rejection
October 28, 2010 2010/45 Gaz CN RAW: Rule 18ter(4) all goods and services protected
January 21, 2010 2010/27 Gaz CH Correction
February 13, 2009 2009/9 Gaz TR RAW: Protection Granted
July 30, 2007 2007/33 Gaz CN Rejection
July 10, 2007 2007/39 Gaz CH Correction
September 20, 2006 2006/41 Gaz CH Correction
January 29, 2004 2004/4 Gaz CH Registration

ID: 14818439